Efficiency of nivolumab in the treatment of second-line advanced non-squamous non-small cell lung cancer (NSCLC) in Spain
Annual Congress of the European Society for Medical Oncology. Madrid. 8-12 sep 2017
Costs of adverse events management associated to the treatment of first-line metastatic renal cell carcinoma with bevacizumab + interferon alpha-2a compared with sunitinib in Spain.
34th Congress of the European Society for Medical Oncology (ESMO). Berlin, Germany. 20-24 sep 2009.